“Ofatumumab: A Second Generation Anti-CD20 Monoclonal Antibody in Chronic Lymphocytic Leukemia”. Hematology Meeting Reports (formerly Haematologica Reports) 3, no. 3 (June 12, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/583.